Ibotta, Inc. (IBTA)
NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-09-04
NYSEInformation TechnologySoftware - ApplicationSnapshot 2026-09-04
Warn: Primary pillar under pressure — Adjusted EBITDA margin improves despite revenue pressure: EBITDA margin -9.7% (Q1) vs -0.8% (prior year); Q2 EBITDA margin not reported.
Ibotta aims to stabilize and grow revenue after declines to $82.48M in 2026-Q1. The company plans to improve profit margins despite challenges. It also expanded its share buyback program by $100 million. These moves could help restore investor confidence.
Revenue has declined steadily from $98.38M in 2024-Q4 to $82.48M in 2026-Q1. The company has missed earnings multiple times recently. Profit margin improvement remains uncertain. The turnaround may stall or fail to materialize.
The stock trades about 31% below our fair value near $48. Analysts expect about 7% revenue growth. The market prices in a cautious recovery but not a full turnaround yet.
Breaks if: margin fails to improve or declines over next 4 quarters
Drive adjusted EBITDA growth and margin expansion through operational discipline and scaling revenue.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment is in a high-risk, potentially turnaround situation. IBTA is working on stabilizing revenue and improving margins, but recent financial performance has been weak and the stock is under watch.
The market seems to have priced in a stretched valuation compared to peers, with expectations that may not fully align with recent earnings performance. There is a low fragility tier, indicating that the current market environment does not present immediate threats.
Management is focused on revenue growth and margin improvement, with recent results showing some positive trends. However, there is a high near-term risk of missing earnings expectations, as the company has struggled with consecutive misses.
The future performance of IBTA hinges on management's ability to stabilize revenue and improve margins, as well as external factors like potential interest rate cuts and performance from sector leaders. A downgrade in guidance could negatively impact sentiment.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports a positive outlook. Revenue stabilization and growth from new partnerships also enhances the investment thesis.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 2 of last 2 quarters. Adjusted EBITDA margin rose from 11% in 2026-Q1 to 18.6% in 2026-Q2, exceeding guidance. The company projects a 14.8% margin in 2026-Q3. The trajectory shows delivering margin improvement consistent with management's stated priority.
“Delivered adjusted EBITDA of $16.5 million, representing an 18.6% adjusted EBITDA margin.”
“Delivered adjusted EBITDA of $8.7 million, representing an 11% adjusted EBITDA margin.”
Breaks if: revenue falls below $82 million next 4 quarters
Focus on returning to year-over-year revenue growth through expanding the Ibotta Performance Network and increasing redemption revenue.
Stated as a priority in 2 of last 2 quarters. Revenue grew from $82.5 million in 2026-Q1 (down 2% YoY) to $88.9 million in 2026-Q2 (up 3% YoY), with redemption revenue growing 10% YoY in 2026-Q2. Management's trajectory shows a return to growth, delivering on the stated priority.
“Returning to top-line growth one quarter ahead of schedule; Redemption revenue grew 10% year-over-year.”
“We believe the ongoing strengthening of our network has us well-positioned to return to year-over-year growth in the third quarter.”
Breaks if: no expansion of buyback program by mid-2026
Continue and expand the share repurchase program to return capital to shareholders.
Stated in 2 of last 2 quarters. The Board increased the share repurchase authorization by $100 million in March 2026. The company repurchased $44.7 million in 2026-Q1 and $23.0 million in 2026-Q2, showing active execution of the expanded program and delivering on capital allocation priorities.
“Repurchased 0.7 million shares for $23.0 million in 2026-Q2.”
“Repurchased 1.9 million shares for $44.7 million in 2026-Q1.”
In the next 1 to 3 years, IBTA's performance will depend on its execution of growth strategies and external market conditions. Not investment advice.